Endoscopic Pituitary Surgery: A Minimally Invasive Approach That Changes How These Tumors Are Treated - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Endoscopic Pituitary Surgery: A Minimally Invasive Approach That Changes How These Tumors Are Treated

For decades, treating pituitary tumors often meant a craniotomy. Large incisions, brain retraction, and longer recovery times were part of the equation, even for benign tumors. That is no longer the standard.

  • By

  • July 7, 2026

  • 7 min

Share

Clinical Report: Endoscopic Pituitary Surgery: A Minimally Invasive Approach

Overview

The endoscopic trans-nasal approach for pituitary tumor removal reduces the need for traditional open skull surgery. This technique utilizes advanced visualization and a collaborative surgical model.

Background

Pituitary tumors are common and traditionally required invasive craniotomy for removal, leading to longer recovery times and increased risks. The minimally invasive endoscopic approach allows for safer and more efficient procedures.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The endoscopic approach eliminates external incisions and brain manipulation, enhancing safety and recovery.
  • Enhanced visualization through angled endoscopes allows for better access to critical structures during surgery.
  • Intraoperative navigation systems improve surgical precision by correlating real-time anatomy with preoperative imaging.
  • The collaborative surgical model involves both a neurosurgeon and an ENT specialist, improving control and efficiency during the procedure.
  • Endoscopic surgery is associated with higher gross total resection rates compared to traditional methods, with comparable complication rates.

Clinical Implications

Multidisciplinary collaboration in surgical teams can enhance procedural safety and effectiveness.

Conclusion

The transition to endoscopic techniques for pituitary tumor removal represents a change in surgical practice.

Related Resources & Content

  1. Yaron Moshel, MD, Giant Lin, MD, Atlantic Health System, 2026 -- Endoscopic Pituitary Surgery: A Minimally Invasive Approach That Changes How These Tumors Are Treated
  2. Yaron Moshel, MD, Giant Lin, MD, Atlantic Health System, 2026 -- Pituitary Tumors: Recognizing the Signs and Knowing When to Act
  3. Int. Journal of Computer Assisted Radiology and Surgery, 2026 -- A benchmark of methods for surgical instrument segmentation in endoscopic pituitary surgery
  4. Congress of Neurological Surgeons, 2026 -- Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas
  5. Neurosurgical Review, 2026 -- Outcomes of endoscopic and microscopic transsphenoidal pituitary surgery: evidence from a systematic review, meta-analysis, and institutional experience
  6. Transcavernous Endoscopic Technique for Treating Functional Pituitary Adenomas
  7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas - PubMed
  8. Outcomes of endoscopic and microscopic transsphenoidal pituitary surgery: evidence from a systematic review, meta-analysis, and institutional experience | Neurosurgical Review | Springer Nature Link
  9. Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement

Original Source(s)

Endoscopic Pituitary Surgery: A Minimally Invasive Approach That Changes How These Tumors Are Treated

  • by

  • July 7, 2026

Related Content

A More Direct Route to Intervention: Baptist Health Expands Surgical Pathways for Drug-Resistant Epilepsy

For patients who continue to have seizures despite appropriate anti-seizure medication therapy, timely referral for surgical evaluation can change the trajectory of care.

  • by

  • July 17, 2026

  • 6 min
Motor mapping to enable resections of peri-rolandic diffuse gliomas

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.